My last article from ICIS this year was just published as part of the SOCMA Leadership 2012 supplement. I was assigned to write an article on how specialty chemicals companies such as Allylix, Rivertop Renewables, and Blue Marble Biomaterials (BMB) are doing amid financing pressures and mainstream media focusing more towards bio-based commodity products as opposed to specialty chemicals.

[scribd id=108577013 key=key-2fuii744x29v2ur1t5wu mode=scroll]